Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | PTGFR | P43088 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL494013 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL495059 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL494900 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL495948 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL494087 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL495251 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL3059308 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL495140 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL494185 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 | |
| SCHEMBL495750 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTP53LTA4HFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118356812-A | Ternary polymerization polyamide composite membrane and preparation method and application thereof | 南京工业大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118356812-A | Ternary polymerization polyamide composite membrane and preparation method and application thereof | 南京工业大学 | 2024-07-19 | — | — | CN | disclosed |
| EP-2605769-B1 | BENZOQUINONE DERIVATIVES FOR THE TREATMENT OF MITCHONDRIAL EYE DISEASES | SANTHERA PHARMACEUTICALS CH (CH) | 2016-07-27 | — | — | EP | disclosed |
| EP-2605769-A2 | BENZOQUINONE DERIVATIVES AS MODULATORS OF MITCHONDRIAL FUNCTION | Santhera Pharmaceuticals (Schweiz) AG (CH) | 2013-06-26 | — | — | EP | disclosed |
| EP-2606022-A2 | NOVEL BENZOQUINONE DERIVATIVES AND USE THEREOF AS MODULATORS OF MITOCHONDRIAL FUNCTION | Santhera Pharmaceuticals (Schweiz) AG (CH) | 2013-06-26 | — | — | EP | disclosed |
| WO-2012022468-A2 | BENZOQUINONE DERIVATIVES AS MODULATORS OF MITCHONDRIAL FUNCTION | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2012-02-23 | — | — | WO | disclosed |
| WO-2012022467-A2 | NOVEL BENZOQUINONE DERIVATIVES AND USE THEREOF AS MODULATORS OF MITOCHONDRIAL FUNCTION | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2012-02-23 | — | — | WO | disclosed |
| US-7772402-B2 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2010-08-10 | — | — | US | disclosed |
| US-20090258422-A1 | OPTICALLY DETECTABLE ORGANOPHOSPHONATES | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2009-10-15 | — | — | US | disclosed |
| US-7601845-B2 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2009-10-13 | — | — | US | disclosed |
| EP-1603927-B1 | OPTICALLY DETECTABLE (ALKYLACYL-2-AMINODESOXY-GLYCERO)-NITROPHENYL-PHOSPHONATES | AUSTRIA WIRTSCHAFTSSERV GMBH (AT) | 2008-08-20 | — | — | EP | disclosed |
| US-20060134715-A1 | Optically detectable organophosphonates | AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (AT) | 2006-06-22 | — | — | US | disclosed |
| EP-1603927-A1 | OPTICALLY DETECTABLE (ALKYLACYL-2-AMINODESOXY-GLYCERO)-NITROPHENYL-PHOSPHONATES | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004083220-A1 | OPTICALLY DETECTABLE (ALKYLACYL-2-AMINODESOXY-GLYCERO)-NITROPHENYL-PHOSPHONATES | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung (AT) | 2004-09-30 | — | — | WO | disclosed |
| US-5942387-A | Combinatorial process for preparing substituted thiophene libraries | ELI LILLY AND COMPANY (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0825164-A2 | Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides | ELI LILLY AND COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258422-A1 | OPTICALLY DETECTABLE ORGANOPHOSPHONATES | LYPLA1, CES1, LIPE | ALDH1A1 1008/4885TSHR 2812/4885TP53 4438/4885 |
| US-20060134715-A1 | Optically detectable organophosphonates | LYPLA1, CES1, LIPE | ALDH1A1 1008/4885TSHR 2812/4885TP53 4438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.